The anti-liver fibrosis effect of Tibetan medicine (Qiwei Tiexie capsule) is related to the inhibition of NLRP3 inflammasome activation in vivo and in vitro

Bibliographic Data

ID14743938
AuthorsShanshan Wang (0000-0002-6882-858X, Beijing University of Chinese Medicine), Fei Ye (0000-0002-0749-7393, Beijing University of Chinese Medicine), Qingjia Ren (Tibetan Traditional Medical College), Shengnan Sun (0000-0002-6962-583X, Beijing University of Chinese Medicine), Weina Xia (Beijing University of Chinese Medicine), Zhuwei Wang (0000-0002-2880-3329, Beijing University of Chinese Medicine), Haolin Guo (Beijing University of Chinese Medicine), Han Li (0000-0002-4579-9552, Beijing University of Chinese Medicine), Shujing Zhang (0000-0001-7757-8482, Beijing University of Chinese Medicine), Scott Lowe (0000-0002-3325-6438, Kansas City University), Meng Chen (0000-0003-4503-5226, Beijing University of Chinese Medicine), Qinghong Du, Qing‐Hong Du (0000-0002-3753-5995, Beijing University of Chinese Medicine, corresponding author), Weihong Li (0000-0002-7775-1342, Beijing University of Chinese Medicine, corresponding author), Weihong Li Weihong Li
Year2024
Volume319
IssuePt 2
Pages117283
Publication date2024-01-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueJournal of Ethnopharmacology (JOURNAL)
Journal identifiersISSN: 0378-8741 • E-ISSN: 1872-7573
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.jep.2023.117283
PMID37827298
OpenAlexW4387493152
LanguageEN
References cited64

Tools

Open DOI